Threshold of Nuchal Translucency for the Detection of Chromosomal Aberration: Comparison of Different Cut-offs by Kim, Min-Hyoung et al.
INTRODUCTION
The first screening method of screening for trisomy 21 was
based on the maternal age. Since the late 1980s, a test was uni-
versalized for three fetoplacental products (alpha-fetoprotein,
unconjugate estriol, and total hCG) in the maternal serum at
the second trimester of gestation. In addition, various sono-
graphic markers such as nuchal fold thickness and femur length
in second trimester were introduced, and the nuchal translu-
cency (NT) became important as the early screening method
for chromosomal abnormality (1-3). The test, using maternal
serum biochemical markers, has a relatively fixed cut-off of
1:270, and the sensitivity is known to be about 60%. Many
studies have reported that the thickened NT could identify
about 75% of affected fetuses for a false positive rate of 5%,
but various cut-offs were used in those studies (4-7).
Although many studies have asserted that different cut-offs
of NT according to the crown rump length (CRL) should be
used for screening chromosomal aberration, there are few stud-
ies actually comparing the sensitivities and false positive rates
of NT with different cut-offs within the same group. In this
study, we report herein on those values of NT for chromosomal
aberration with three different cut-offs, 2.5 mm, 3.0 mm and
the 95th percentile for the CRL in a Korean population. 
MATERIALS AND METHODS
This study was conducted with 2,570 pregnancies by sear-
ching our clinical database from January 2001 through De-
cember 2001. The inclusion criteria were singleton pregnan-
cies who examined ultrasonographic fetal NT measurement
between 11 weeks and 14 weeks of gestation at our institution
and performed regular antenatal care during the pregnancy
with known pregnancy outcome. Pregnancy outcomes were
ascertained from the obstetric and neonatal medical records.
This study was approved by the institutional review board.
The ultrasonographic scans of fetal NT measurement were
carried out by 5 sonographers and 2 obstetricians experienced
first-trimester scans more than 5 yr. Fetal NT thickness was
measured using the transabdominal ultrasonography (HDI
3000, ATL, Bothell, WA, U.S.A.) in a good mid-sagittal
section of the fetus with magnification so that the fetus occu-
pied at least 75% of the image (8). In cases of visualization
proved difficult or suspicious findings, a transvaginal ultra-
sonography was also used. The NT was defined as the black
area between the inner skin on the outline echo and the outer
border of the soft tissue overlying the cervical spine. The max-
imal thickness of the black area was measured with a caliper
placed on the lines to 0.1 mm when the sagittal section of the
fetuses was obtained. At same time, the fetal CRL was also
measured. The range of fetal CRL was from 45 mm to 84 mm.
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Threshold of Nuchal Translucency for the Detection of Chromosomal
Aberration: Comparison of Different Cut-offs
This study evaluated the sensitivities and false positive rates of the screening test
using ultrasonographic measurement of thickness of nuchal translucency (NT) with
different cut-offs for chromosomal aberration in a Korean population. We included
2,570 singleton pregnancies undergoing ultrasound between 11 weeks and 14 weeks
of gestation in this study. We analyzed the sensitivities of NT alone for screening
chromosomal aberration using three cut-offs -2.5 mm, 3.0 mm, and 95th percentile
for each crown rump length (CRL). There were 31 chromosomal aberrations (1.2%)
including 12 cases of trisomy 21. The numbers of chromosomal aberrations that
were detected by NT with different cut-offs of 2.5 mm, 3.0 mm and the 95th percentile
CRL were 22, 18 and 23, respectively. At a threshold of 2.5 mm, the sensitivity and
the false positive rate for total chromosomal aberrations were 67.7% and 6.3%, res-
pectively. At 3.0 mm, those were 54.8% and 3.5%, respectively. At the 95th percentile
CRL, those were 70.9% and 5.8%, respectively. The use of CRL-dependent cut-offs
for nuchal translucency improves the detection of chromosomal aberrations when
compared to fixed cut-offs in a Korean population.
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Great care was also taken to clearly distinguish between the
fetal skin and the amniotic membrane. In some cases this
could only be achieved by asking the mother to cough or by
tapping the maternal abdomen. In some cases, it was helpful
to use the cineloop function (a function that permits the replay
of ultrasound images taken in the past few seconds) to visu-
alize the fetus in a satisfactory position. At least three mea-
surements were taken during the scan and the largest of the
three measurements was recorded. 
We underwent fetal karyotyping in one hundred twenty
five women with increased fetal NT (≥2.5 mm) by chorionic
villus sampling or amniocentesis. Fetal karyotyping was also
offered to women who were maternal age of 35 yr old or more
at the time of delivery (n=158), had a positive result on the
triple test (n=92), had the history of chromosomal abnor-
mality in any previous pregnancy (n=8), had major fetal struc-
tural anomalies on ultrasound examination (n=12), and oth-
ers (n=24). The karyotyping was also performed in Intrauter-
ine fetal death (IUFD) (n=4) cases. Among the cases who had
not been offered fetal karyotyping, we examined the neonates
or stillborn for phenotypic abnormality indicating chromo-
somal aberrations. We excluded the cases (n=8) who had ter-
minated their pregnancies because of major structural anoma-
ly on antenatal ultrasound without fetal karyotyping.
The frequencies of chromosomal aberrations were analyzed
and the sensitivities and false positive rates were calculated
according to three different cut-offs, namely 2.5 mm, 3.0 mm
and the 95th percentile for each fetal CRL. We used the data
about the 95th percentile of NT for each CRL of our insti-
tution (9). 
RESULTS
A total of 2,570 single pregnancies were included in our
analysis. The mean maternal age was 29.9±3.3 yr old. The
mean CRL was 60.1±9.1 mm. The frequencies of fetuses
with increased NT according to cut-offs of 2.5 mm, 3.0 mm,
and the 95th percentile of each CRL were 7.1%, 4.1% and
6.5% respectively.
Table 1 shows the types and frequencies of chromosomal
aberrations according to the various cut-offs of NT. There
were a total of 31 cases (1.2%) of chromosomal aberrations
in this study. Among these cases, trisomy 21 was most fre-
quent chromosomal aberration (38.7% [12/31]). The frequen-
cies of chromosomal aberrations that ultrasonographic NT
measurement was thickened than that of 2.5 mm, 3.0 mm,
and the 95th percentile of NT measurement at each CRL were
11.5% (21/161), 15.9% (17/89), and 13.2% (22/146), respec-
tively. We could detect one more case of trisomy 18 when we
used the 95th percentile as the cut-off than the fixed cut-off
of 2.5 mm. 
Table 2 shows the sensitivities and false positive rates of
NT with each cut-off for screening all the chromosomal aber-
rations and trisomy 21. The sensitivity for detection of chro-
mosomal aberrations was high (70.9%) in the 95th percentile
as the cut-off compared with the fixed cut-offs. The false posi-
tive rate was 3.5% when using 3.0 mm, but the sensitivity
was 54.8%. When using the 95th percentile of NT, the sen-
sitivity was higher and the false positive rate was lower than
those of using 2.5 mm for detecting chromosomal aberrations.
The sensitivities of the NT measurement to detect trisomy
21 with two cut-offs, 2.5 mm and the 95th percentile were
same (75%), and the false positive rate of the 95th percentile
(6.2%) was lower than that of 2.5 mm (6.8%). 
DISCUSSION
The various screening methods for detecting chromosomal
aberration have been investigated and many studies are ongo-
ing to search for a more efficient screening method. Among
the various methods, we evaluated the sensitivities and false
positive rates of the screening test of NT measurement alone
(not including maternal age) in the first trimester for chromo-
somal aberrations by using three different cut-offs in a Kore-
an population. 
Others: 47,XX+21/46,XX, de novo 45,XX t(13;14) (q10;q10), 47,XY+
MAR/46,XY, 45,X/46,X+MAR, 46,XX/46,XY.
≥95th
percentile
Normal 2,539 161 89 146
Abnormal 31 21 17 22
Trisomy 21 12 9 6 9
Trisomy 18 5 4 3 5
Trisomy 13 3 2 2 2
45, XO 2 2 2 2
47, XXX 1 1 1 1
47, XXY 1 0 0 0
Others 7 3 3 3
Total 2,570 182 106 168
Table 1. Types and frequencies of chromosomal aberrations
according to different cut-offs of NT in 2,570 cases
Cut-off of NT
≥2.5 mm ≥3.0 mm
PPR, Positive predictive rate; FPR, False positive rate.
95th 
percentile
Sensitivity 67.7% 75.0% 54.8% 50.0% 70.9% 75.0%
Specificity 93.7% 93.2% 96.5% 96.1% 94.2% 93.8%
PPR 11.5% 5.2% 16.0% 6.0% 13.1% 5.7%
FPR 6.3% 6.8% 3.5% 3.9% 5.8% 6.2%
Table 2. Sensitivity, specificity, positive predictive rate, false posi-
tive rate of each cut-off of NT for screening all chromosomal aber-
rations and trisomy 21
Cut-off of NT
2.5 mm 3.0 mm
All Trisomy All Trisomy All Trisomy 
21 21 21
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The sensitivity of the NT measurement with 3.0 mm as a
cut-off was 54.8% in this study. The early studies about NT
measurement mainly used 3.0 mm as the cut-off and the re-
ported various sensitivities were from 39% through 93% (10-
12). This wide range of results may be due to the different
study populations and/or to an inadequate gestational age at
the time of NT measurement. Most of these studies were
mainly targeted to a high risk population that was scheduled
for fetal karyotyping (11, 12), so the sensitivity of detecting
an affected fetus with an increased NT would be higher than
that used in the general population. On the other hand, some
early studies reported low sensitivity in their results (13, 14).
In those studies, the adequate gestational age (in weeks) of
the NT measurement was not established, so cases that mea-
sured earlier than 11 weeks of gestation were also included
as a large proportion of the subjects. All the cases in which
the translucency was not visible or measurable were includ-
ed in the classification of less than 1.0 mm. The cases under
10 weeks of gestational age had the probability of having an
immeasurable NT, and the studies that included these sub-
jects would have results with low sensitivity. Currently, the
adequate period of the NT measurement is known to be the
time between 11 and 14 weeks of gestation (8). In this study,
we included pregnant woman in this period.
As extensive data is accumulated regarding the first-tri-
mester NT screening of populations at high risk, attention
has been drawn to those populations at low risk and general
population (15-17). This data is of major importance because
these populations represent the women for whom the vast
majority of pregnancies with fetuses having abnormal chro-
mosomes will occur. 
The results of the present study are similar to those results
of Hafner et al. (16). They assessed what percentage of chro-
mosomal anomalies could be detected by a NT measured in
4,233 unselected women. They diagnosed one additional
Down syndrome case by using a sliding scale for the cut-off
value with two standard deviations instead of the fixed value
of 2.5 mm. So, they suggested that detection rate could prob-
ably be improved by raising the values with increasing ges-
tational age. We used the 95th percentile of each CRL as the
cut-off value in this study, and we could detect one additional
case of trisomy 18.
Recent studies have reported the sensitivities of NT accord-
ing to various gestational age-dependent cut-offs for detect-
ing chromosomal abnormality (15, 17, 18). One of the largest
multicenter study (18) showed that the sensitivity of NT with
gestational age-dependent cut-offs for trisomy 21 was 77%
for a false positive rate of 5%. 
The frequency of trisomy in our study is higher than that
of other studies. We presume the reason for high occurrence
of trisomy in this study is that we included two cases of tri-
somy referred from private clinics with abnormal ultrasound
findings in first trimester and another two cases of trisomy
with IUFD before amniocentesis (The NT thickness of those
cases were all increased over 3 mm). Although the sensitivi-
ties and false positive rates of NT for detecting of chromoso-
mal aberration were changed after excluding those four cases
(62.9%, 48.1%, 66.6% and 6.4%, 3.6%, 5.8% according
to cut-offs 2.5 mm, 3.0 mm, 95th percentile), the superior-
ity of 95th percentile NT value as the cut-off for screening
test was not changed.
This study is the first study to compare the sensitivities of
nuchal translucency alone as a screening test for chromoso-
mal aberration with different cut-offs in a Korean popula-
tion. When using the 95th percentile of NT, we identified
that the sensitivity was higher than that of fixed cut-off for
detecting chromosomal aberrations. So, we can suggest that
this cut-off should be used for the nuchal translucency mea-
surement screening method in Korean population.
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